Connect with us
HIG Capital has formed the newco Luna BidCo srl, which will buy 100 percent of Polygon's share capital. The deal promises to be of a certain...
Exheus analyzes the expression of all the genes in the human body present in the blood transcriptome to detect and correct anomalies that affect a person's...
In addition to the factory expansion project, iVascular estimates that over the next five years it will allocate €40 million to investments in research, development, and...
Santana will be responsible, among other tasks, for Doctomatic's deployment in Latin America, which the company expects to be completed within the next year after having...
Asian dependence has become even more evident with Covid-19. China exports more than 40% of active pharmaceutical ingredients. Europe has gradually lost its leading position in...
Merck MSD acquired Imago BioSciences and expects the deal to close in the first quarter of 2023. Novo Nordisk will invest €726 million (DKK 5.4 billion)...
Beyond the 27 EU countries, the pharmaceutical industry maintains its relevance in Switzerland and ranks as the country's second most exported non-agricultural product, followed by blood...
If this round is successfully completed, Mediquo would add its sixth operation of this size. In April 2021, Encomenda Smart Capital and Dozen Investments led a...
Janssen increased its profit to €72.2 million last year. In total, Johnson&Johnson expects year-end revenue to be between $93 billion and $93.5 billion, while it expects...
Algernon Pharmaceuticals Inc. is a Canadian clinical-stage drug development company with a promising new treatment for post-stroke recovery based on sub-psychedelic doses of DMT. The company...
 |
|
 |  |
 |
|